Скачать или смотреть Interview with Global Biotech Revolution's Advisory Board Chair, Sir Gregory Winter

Sir Gregory Winter, Master, Trinity College, University of Cambridge

Sir Gregory Winter FRS is Master of Trinity College Cambridge and until recently a member of the Medical Research Council’s Laboratory of Molecular Biology (LMB) in Cambridge. He is a scientist, inventor and entrepreneur. His work has involved the development of technologies for making pharmaceutical antibodies by genetic engineering. Such antibodies have proved useful for treatment of cancer and immune disorders, and now comprise many of the world’s top selling pharmaceutical drugs. In order to see his technologies applied, Sir Gregory founded Cambridge Antibody Technology and Domantis (both acquired in 2006), and most recently Bicycle Therapeutics, which is developing a peptide product for treatment of cancer.